首页|益气解毒化瘀汤联合同步放化疗治疗老年食管癌患者的临床疗效及对其生活质量的影响

益气解毒化瘀汤联合同步放化疗治疗老年食管癌患者的临床疗效及对其生活质量的影响

扫码查看
目的 观察益气解毒化瘀汤联合同步放化疗治疗老年食管癌患者的临床疗效及对其生活质量的影响.方法 选取2019年1月-2021年12月期间河北省退役军人总医院、邢台市人民医院及邢台医专附属二院住院的老年食管癌患者82例作为研究对象,按随机数字表法分为对照组和观察组,每组各41例.对照组给予同步放化疗,观察组在对照组基础上给予益气解毒化瘀汤.治疗1个月后,观察比较两组患者临床疗效、不良反应情况,治疗前后KPS评分、生活质量评分.结果 治疗后观察组患者总有效率75.61%(31/41)明显高于对照组51.22%(21/41),差异有统计学意义(P<0.05).治疗后两组患者KPS评分均较治疗前升高,差异有统计学意义(P<0.001);且观察组KPS评分明显高于对照组,差异有统计学意义(P<0.05).治疗后两组患者SF-36评分均较治疗前升高,差异有统计学意义(P<0.05);且观察组SF-36评分均明显高于对照组,差异有统计学意义(P<0.05).治疗期间,观察组放射性肺炎、骨髓抑制和胃肠道反应发生率(7.3%、26.8%、36.6%)明显低于对照组(29.3%、48.8%、58.5%),差异有统计学意义(P<0.05).结论 益气解毒化瘀汤联合同步放化疗可以提高不宜手术的老年食管癌患者临床疗效,改善其体力状况,提高生活质量,减少不良反应.
Clinical Efficacy of Yiqi Jiedu Huayu Decoction Combined with Concurrent Chemo-radiotherapy on Elderly Patients with Esophageal Cancer and Its Effect on Quality of Life of Patients
Objective To observe the clinical efficacy of Yiqi Jiedu Huayu Decoction combined with concurrent chemoradiotherapy in the treatment of elderly patients with esophageal cancer and its impact on their quality of life.Meth-ods Eighty-two elderly inpatients with esophageal cancer admitted to Hebei General Hospital for Veterans,Xingtai Peo-ple's Hospital,and the Second Affiliated Hospital of Xingtai Medical College between January 2019 and December 2021 were enrolled and randomly divided into a control group and an observation group,with 41 patients in each group.The con-trol group received concurrent chemoradiotherapy,while the observation group received Yiqi Jiedu Huayu Decoction in ad-dition to the treatment given to the control group.After one month of treatment,the clinical efficacy,adverse reactions,Karnofsky Performance Status(KPS)score,and quality of life score of the two groups were compared before and after treat-ment.Results After treatment,the overall effective rate in the observation group was 75.61%(31/41),significantly high-er than 51.22%(21/41)in the control group(P<0.05).After treatment,both groups showed a statistically significant in-crease in KPS scores compared to those before treatment(P<0.001),with the observation group showing a significantly higher KPS score than the control group(P<0.05).Both groups also exhibited a statistically significant increase in SF-36 scores after treatment compared to those before treatment(P<0.05),with the observation group scoring significantly higher than the control group(P<0.05).During the treatment period,the incidence rates of radiation pneumonitis,myelo-suppression,and gastrointestinal reactions in the observation group(7.3%,26.8%,and 36.6%)were significantly lower than those(29.3%,48.8%,58.5%)in the control group(P<0.05).Conclusion Yiqi Jiedu Huayu Decoction com-bined with concurrent chemoradiotherapy can improve clinical efficacy in elderly patients with esophageal cancer who are not suitable for surgery,enhance their physical condition,improve their quality of life,and reduce adverse reactions.

Esophageal CancerElderly PatientsYiqi Jiedu Huayu DecoctionConcurrent ChemoradiotherapyQuality of life

吕莹、陈月静、牛哲、王鑫、冯雷、郭秋峰、王玉强

展开 >

河北省退役军人总医院,河北邢台 054000

邢台市第三医院,河北邢台 054000

邢台市人民医院,河北邢台 054000

食管癌 老年 益气解毒化瘀汤 同步放化疗 生活质量

邢台市科技计划

2021ZC067

2024

世界中西医结合杂志
中华中医药学会

世界中西医结合杂志

CSTPCD
影响因子:1.053
ISSN:1673-6613
年,卷(期):2024.19(5)
  • 13